257 related articles for article (PubMed ID: 16778191)
1. Different progression of tumor xenografts between mucin-producing and mucin-non-producing mammary adenocarcinoma-bearing mice.
Sugihara I; Yoshida M; Shigenobu T; Takagi H; Maruyama K; Takeuchi N; Toda M; Inoue M; Nakada H
Cancer Res; 2006 Jun; 66(12):6175-82. PubMed ID: 16778191
[TBL] [Abstract][Full Text] [Related]
2. Ligation of tumour-produced mucins to CD22 dramatically impairs splenic marginal zone B-cells.
Toda M; Hisano R; Yurugi H; Akita K; Maruyama K; Inoue M; Adachi T; Tsubata T; Nakada H
Biochem J; 2009 Feb; 417(3):673-83. PubMed ID: 18925876
[TBL] [Abstract][Full Text] [Related]
3. Down-modulation of B cell signal transduction by ligation of mucins to CD22.
Toda M; Akita K; Inoue M; Taketani S; Nakada H
Biochem Biophys Res Commun; 2008 Jul; 372(1):45-50. PubMed ID: 18474217
[TBL] [Abstract][Full Text] [Related]
4. Specific immunosuppressive activity of epiglycanin, a mucin-like glycoprotein secreted by a murine mammary adenocarcinoma (TA3-HA).
Fung PY; Longenecker BM
Cancer Res; 1991 Feb; 51(4):1170-6. PubMed ID: 1825477
[TBL] [Abstract][Full Text] [Related]
5. Isolation and partial characterization of an epiglycanin-like glycoprotein from a new non-strain-specific subline of TA3 murine mammary adenocarcinoma.
Codington JF; Cooper AG; Miller DK; Slayter HS; Brown MC; Silber C; Jeanloz RW
J Natl Cancer Inst; 1979 Jul; 63(1):153-61. PubMed ID: 286825
[TBL] [Abstract][Full Text] [Related]
6. Loss of strain specificity of the TA3-St subline: evidence for the role of epiglycanin in mouse allogeneic tumor growth.
Cooper AG; Codington JF; Miller DK; Brown MC
J Natl Cancer Inst; 1979 Jul; 63(1):163-9. PubMed ID: 221714
[TBL] [Abstract][Full Text] [Related]
7. Further studies on the relationship between allotransplantability and the presence of the cell surface glycoprotein epiglycanin in the TA3-MM mouse mammary carcinoma ascites cell.
Miller SC; Codington JF; Klein G
J Natl Cancer Inst; 1982 Jun; 68(6):981-8. PubMed ID: 6953278
[TBL] [Abstract][Full Text] [Related]
8. The role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. I. Induction of regulatory macrophages in normal mice by the in vivo administration of rGM-CSF.
Fu YX; Watson GA; Kasahara M; Lopez DM
J Immunol; 1991 Jan; 146(2):783-9. PubMed ID: 1824777
[TBL] [Abstract][Full Text] [Related]
9. Identification and expression of human epiglycanin/MUC21: a novel transmembrane mucin.
Itoh Y; Kamata-Sakurai M; Denda-Nagai K; Nagai S; Tsuiji M; Ishii-Schrade K; Okada K; Goto A; Fukayama M; Irimura T
Glycobiology; 2008 Jan; 18(1):74-83. PubMed ID: 17977904
[TBL] [Abstract][Full Text] [Related]
10. Potential involvement of the cyclooxygenase-2 pathway in hepatocellular carcinoma-associated angiogenesis.
Zhao QT; Yue SQ; Cui Z; Wang Q; Cui X; Zhai HH; Zhang LH; Dou KF
Life Sci; 2007 Jan; 80(5):484-92. PubMed ID: 17097688
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis.
Iwata C; Kano MR; Komuro A; Oka M; Kiyono K; Johansson E; Morishita Y; Yashiro M; Hirakawa K; Kaminishi M; Miyazono K
Cancer Res; 2007 Nov; 67(21):10181-9. PubMed ID: 17974958
[TBL] [Abstract][Full Text] [Related]
12. Muscarinic receptors autoantibodies purified from mammary adenocarcinoma-bearing mice sera stimulate tumor progression.
Fiszman G; Cattaneo V; de la Torre E; Español A; Colombo L; Sacerdote de Lustig E; Sales ME
Int Immunopharmacol; 2006 Aug; 6(8):1323-30. PubMed ID: 16782546
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells.
Sinha P; Clements VK; Fulton AM; Ostrand-Rosenberg S
Cancer Res; 2007 May; 67(9):4507-13. PubMed ID: 17483367
[TBL] [Abstract][Full Text] [Related]
14. Conjugated linoleic acid (CLA) modulates prostaglandin E2 (PGE2) signaling in canine mammary cells.
Wang LS; Huang YW; Liu S; Chang HL; Ye W; Shu S; Sugimoto Y; Funk JA; Smeaks DD; Hill LN; Lin YC
Anticancer Res; 2006; 26(2A):889-98. PubMed ID: 16619484
[TBL] [Abstract][Full Text] [Related]
15. Different mechanisms lead to the angiogenic process induced by three adenocarcinoma cell lines.
Davel LE; Rimmaudo L; Español A; de la Torre E; Jasnis MA; Ribeiro ML; Gotoh T; de Lustig ES; Sales ME
Angiogenesis; 2004; 7(1):45-51. PubMed ID: 15302995
[TBL] [Abstract][Full Text] [Related]
16. Ephrin-A1 facilitates mammary tumor metastasis through an angiogenesis-dependent mechanism mediated by EphA receptor and vascular endothelial growth factor in mice.
Brantley-Sieders DM; Fang WB; Hwang Y; Hicks D; Chen J
Cancer Res; 2006 Nov; 66(21):10315-24. PubMed ID: 17079451
[TBL] [Abstract][Full Text] [Related]
17. Induction of alpha-N-acetylgalactosamine-O-serine/threonine (Tn) antigen-mediated cellular immune response for active immunotherapy in mice.
Singhal A; Fohn M; Hakomori S
Cancer Res; 1991 Mar; 51(5):1406-11. PubMed ID: 1997178
[TBL] [Abstract][Full Text] [Related]
18. The crucial role of cyclooxygenase-2 in osteopontin-induced protein kinase C alpha/c-Src/IkappaB kinase alpha/beta-dependent prostate tumor progression and angiogenesis.
Jain S; Chakraborty G; Kundu GC
Cancer Res; 2006 Jul; 66(13):6638-48. PubMed ID: 16818637
[TBL] [Abstract][Full Text] [Related]
19. Muscarinic receptors are involved in LMM3 tumor cells proliferation and angiogenesis.
Rimmaudo LE; de la Torre E; Sacerdote de Lustig E; Sales ME
Biochem Biophys Res Commun; 2005 Sep; 334(4):1359-64. PubMed ID: 16040004
[TBL] [Abstract][Full Text] [Related]
20. Modulation of IFN-gamma production by TNF-alpha in macrophages from the tumor environment: significance as an angiogenic switch.
Lee H; Baek S; Joe SJ; Pyo SN
Int Immunopharmacol; 2006 Jan; 6(1):71-8. PubMed ID: 16332515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
